View by Specialty

Trending

Graphical depiction of data presented in article
October 09, 2024
4 min read
Save

COVID-19 a CV risk equivalent to prior heart disease; type O blood may be protective

Neurology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
November 09, 2021
2 min read
Save

Greater fish consumption tied to lower cerebrovascular disease risk

Greater fish consumption tied to lower cerebrovascular disease risk

Eating more fish appeared linked to lower cerebrovascular disease risk, particularly among individuals younger than 75 years, according to results of a population-based study published in Neurology.

SPONSORED CONTENT
November 09, 2021
2 min read
Save

Revised criteria shorten time to MS diagnosis

The 2017 McDonald criteria shortened time to diagnosis of MS compared with the 2010 McDonald criteria, according to study results published in Neurology.

Trending

Graphical depiction of data presented in article
October 09, 2024
4 min read
Save

COVID-19 a CV risk equivalent to prior heart disease; type O blood may be protective

SPONSORED CONTENT
November 09, 2021
1 min read
Save

Dozens of countries promise to lower carbon intensity of health systems

Dozens of countries promise to lower carbon intensity of health systems

Forty-seven countries, including the United States, have committed to developing climate-resilient and low-carbon health systems. They announced their efforts during the UN Climate Change Conference in Glasgow, also known as COP26.

SPONSORED CONTENT
November 08, 2021
2 min read
Save

Vitamin D, omega-3 supplements reduced risk for incident autoimmune disease

Vitamin D, omega-3 supplements reduced risk for incident autoimmune disease

The use of vitamin D3 or omega-3 fatty acid supplements over a 5-year period may reduce the incidence of autoimmune disease in older adults by 25% to 30%, according to data presented at ACR Convergence 2021.

SPONSORED CONTENT
November 08, 2021
2 min read
Save

Researchers report dose-response association for physical activity, all-cause PD mortality

Researchers report dose-response association for physical activity, all-cause PD mortality

Physical activity and all-cause mortality in Parkinson’s disease may have a dose-response association, according to results of a nationwide population-based cohort study published in JAMA Neurology.

SPONSORED CONTENT
November 08, 2021
1 min read
Save

FDA OKs trial to test stroke treatment in distal brain regions

The FDA has granted investigational device exemption approval to Rapid Medical for a trial to expand stroke treatment to distal brain regions, according to a press release.

SPONSORED CONTENT
November 08, 2021
30 min listen
Save

Town Hall: Booster Shots

Town Hall: Booster Shots

In this episode, Joel M. Gelfand, MD, MSCE, and Leonard H. Calabrese, DO, are joined by Carlos del Rio, MD, as they discuss the use of booster shots in the general population and in patients with underlying autoimmunity.

SPONSORED CONTENT
November 08, 2021
4 min read
Save

Commentary: We must act now to make medicines affordable

Commentary: We must act now to make medicines affordable

We have a once-in-a-generation opportunity to make medicines affordable for our patients and support the health needs of every family in our nation. As physicians, now is the time to elevate the voices of our patients and act.

SPONSORED CONTENT
November 05, 2021
1 min read
Save

Health worse in patients concerned about developing drug-induced movement disorders

Health worse in patients concerned about developing drug-induced movement disorders

Patients from community mental health centers who expressed concerns about developing drug-induced movement disorders tended to report worse health and daily functioning, according to study results presented at NEI Congress.

SPONSORED CONTENT
November 05, 2021
2 min read
Save

Cost-effectiveness estimates for Alzheimer’s drugs should consider effects on caregivers

Cost-effectiveness estimates for Alzheimer’s drugs should consider effects on caregivers

Estimating treatment effects on caregivers can help determine the cost-effectiveness of treatments for Alzheimer’s disease, according to results of an economic evaluation published in JAMA Network Open.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails